STACEY PNIEWSKI: Open Payments
NPI 1770710998 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$637 in 21 payments from 14 companies in 2025. Trend: 2023 $789 · 2024 $1,098 · 2025 $637
Food & beverage: $637
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $145 |
| PFIZER INC. | 4 | $111 |
| Lundbeck LLC | 1 | $104 |
| Teva Pharmaceuticals USA, Inc. | 1 | $45 |
| Sumitomo Pharma America, Inc. | 2 | $45 |
| Novo Nordisk Inc | 2 | $38 |
| Daiichi Sankyo Inc. | 1 | $28 |
| IBSA Pharma Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $22 |
| Astellas Pharma US Inc | 1 | $20 |
Products named: VRAYLAR, REXULTI, AUSTEDO XR, Wegovy, VYNDAQEL, MYFEMBREE, INJECTAFER, Tirosint.
Industry payments across MI — which companies pay providers there.
